$1.35
-0.06 (-4.26%)
Novavax, Inc. (NASDAQ:NVAX)
CAPS Rating:
A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.
RSS Headlines
Fool UK